The safety evaluation of endoscopic therapy against patients receiving anticoagulants agents.

The safety evaluation of endoscopic therapy against patients receiving anticoagulants agents. - The safety evaluation of endoscopic therapy during anticoagulants therapy.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000025164

Enrollment

100

Registered

2016-12-06

Start date

2017-01-01

Completion date

Unknown

Last updated

2025-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergoing gastrointestinal endoscopic therapy during anticoagulant therapy

Interventions

endoscopic therapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria:

Exclusion criteria

Exclusion criteria: (A)INR exceeding the upper limit shown in the guideline by Japanese circulation society. (B)The patient who takes other antiplatelet agents

Design outcomes

Primary

Measure	Time frame
Gastrointestinal bleeding during two weeks after endoscopic therapy.	—

Countries

Japan

Contacts

Public Contactkazuki Kakimoto

Osaka Medical College Second department of internal medicine

kazuki1977924@yahoo.co.jp0726831221

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Feb 4, 2026